选择语言

PerCP-Cy5.5 Labeled Monoclonal Anti-Human CD45 Antibody, Mouse IgG2a

用户评价
货号-规格
价格
Qty.
FABm007-06-50tests
¥1940.00
合计0件 产品金额¥ 0

产品详情

  • 应用(Application)

    Flow Cytometry (Evaluation of the expression of CD45 on Human cells).

  • 种属(Species)

    Mouse

  • 亚型(Isotype)

    Mouse IgG2a

  • 特异性(Specificity)

    This product is a specific antibody specifically reacts with CD45 protein.

  • 种属反应性(Reactivity)

    Human

  • 偶联(Conjugate)

    PerCP-Cy5.5

    Excitation Wavelength: 488 nm

    Emission Wavelength: 690 nm

  • 推荐稀释比(Recommended Dilution)

    1:20

  • 制剂(Formulation)

    Supplied as 0.2 μm filtered solution in PBS, 0.2% BSA, 0.03% Proclin 300, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 存储(Storage)

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. Store at 2-8 °C for 12 months.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

产品展示

  • 活性(Bioactivity)-FACS

     CD45 FACS

    Flow cytometric analysis of Human peripheral blood lymphocytes respectively staining with PerCP-CY5.5-Labeled Anti-Human CD45 Antibody, mouse IgG2a (AIRFS225-240625F1-Bulk) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 2.5e5 cells in a final volume of 100 µL), compared with isotype control antibody. PerCP-CY5.5 signal was used to evaluate the binding activity (QC tested).

    Protocol

用户评价
发表评论

背景介绍

CD45 is a receptor protein tyrosine phosphatase, also known as Ly-5 or leukocyte common antigen. CD45 mainly involves in the initiation of T cell receptor signaling by controlling the activation of the Src family protein-tyrosine kinases Lck and Fyn. CD45 deficiency causes in T- and B-lymphocyte dysfunction in the form of severe combined immune deficiency. It also takes a significant role in autoimmune diseases and cancer as well as in infectious diseases including fungal infections.

前沿进展

 
药物研发进展
  • 英文全称:

    Leukocyte common antigen

  • 中文全称:

    白细胞共同抗原

  • 种类:

  • 上市药物数量:

    0 详情

  • 临床药物数量:

    3 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
  • 产品SKU
  • 产品详情
  • 产品展示
  • 用户评价
  • 背景介绍